Drug Discovery Informatics Market Emerging Trends and Key Drivers to 2028

Drug Discovery Informatics Industry Overview

The global drug discovery informatics market size was valued at USD 2.39 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 11.3% from 2021 to 2028. The drug discovery informatics market is set to gain momentum in the coming years due to advancements in high-performance computing & web services, increasing adoption of in-silico modeling tools, the growing volume of drug discovery data, and rising demand for novel medicine moieties. The launch of advanced drug discovery information technology is set to intensify the industry competition. For instance, in January 2021, Certara, Inc. launched Simcyp Physiologically-based Pharmacokinetic (PBPK) Simulator platform version 20. The new models help in assessing and analyzing the drug action during pregnancy and lactation.

Gather more insights about the market drivers, restrains and growth of the Global Drug Discovery Informatics Market

In addition, it helps the customers with critical decisions regarding optimizing medicine safety and efficacy profile. Companies are also increasingly adopting informatics solutions to shorten the long drug discovery timeline. For instance, in December 2020, Curve Therapeutics Ltd. implemented the CDD Vault platform for managing its genetically encoded Microcycle platform. It is a ubiquitous hosted platform suitable for applications across pharmaceutical, biotechnology, and academic institutes for securing and seamless sharing of data in real-time, thereby facilitating collaborative discoveries.

Moreover, the accelerated Covid-19 drug discovery around the world is further contributing to the market growth. For instance, for providing fast-track solutions, scientists performed virtual screening using medicine from the DrugBank, for targeting the viral proteins and human ACE2 receptors. These studies were based on in silico tools for screening small molecules that have the potential usage in drug discoveries against Covid-19.

Similarly, companies are developing several web services & solutions for supporting various steps of drug development for Covid-19. For instance, in June 2020, the IBM visual molecular explorer platform explored a selected set of the generated molecules targeting the coronavirus (SARS-CoV-2). The open-source sharing of the AI-generated artefacts in the explorer helped in the initial stages of optimal medicine designing.

Browse through Grand View Research's Pharmaceuticals Industry Research Reports.

• Peptide Antibiotics Market: The global peptide antibiotics market size was valued at USD 4.37 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 4.6% from 2022 to 2030. The factors responsible for driving the growth of the market are increasing demand of peptide antibiotics in hospitals and clinics, increasing prevalence of diseases such as, bacterial skin infections, blood stream infections, and hospital acquired infections.

• Specialty Generics Market: The global specialty generics market size was valued at USD 67.2 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.2% from 2022 to 2030. The increasing adoption of specialty generic medicines for the treatment of complex chronic diseases such as hepatitis C and their increasing prevalence is a key driver for the market.

Drug Discovery Informatics Market Segmentation

Grand View Research has segmented the global drug discovery informatics market on the basis of workflow, mode, services, and region:

Drug Discovery Informatics Workflow Outlook (Revenue, USD Million, 2017 - 2028)

• Discovery Informatics

• Development Informatics

Drug Discovery Informatics Mode Outlook (Revenue, USD Million, 2017 - 2028)

• Outsourced

• In-house

Drug Discovery Informatics Services Outlook (Revenue, USD Million, 2017 - 2028)

• Sequence Analysis Platforms

• Molecular Modeling

• Docking

• Clinical Trial Data Management

• Others Services

Drug Discovery Informatics Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

Key Companies profiled:

Some prominent players in the Global Drug Discovery Informatics Market include

• Certara

• Boehringer Ingelheim International GmbH

• Infosys Ltd.

• Charles River Laboratories

• Eurofins DiscoverX Products

• Jubilant Biosys

• Selvita

• Novo Informatics Pvt. Ltd.

• ChemAxon Ltd.

• Albany Molecular Research Inc.

• Oracle

• Accenture

• Agilent Technologies, Inc.

• Illumina, Inc.

Order a free sample PDF of the Drug Discovery Informatics Market Intelligence Study, published by Grand View Research.